Chargement en cours...
New Therapeutic Options for Advanced Hepatocellular Carcinoma
Hepatocellular carcinoma (HCC), one of the most common lethal diseases in the world, has a 5-year survival rate of only 7%. Hepatocellular carcinoma has no symptoms in the early stage but obvious symptoms in the late stage, leading to delayed diagnosis and reduced treatment efficacy. In recent years...
Enregistré dans:
| Publié dans: | Cancer Control |
|---|---|
| Auteurs principaux: | , , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
SAGE Publications
2020
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7791453/ https://ncbi.nlm.nih.gov/pubmed/32799550 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1073274820945975 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|